Bellevue Group’s Eupraxia Pharmaceuticals EPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$23.6M Buy
+2,595,139
New +$18.5M 0.49% 46

Other funds holding EPRX

Bellevue Group's EPRX Position: Q3 2026 in Review

Bellevue Group opened a new position in Eupraxia Pharmaceuticals (EPRX) in Q3 2026: 2,595,139 shares worth $23.6M. The stake represents 0.49% of the portfolio and ranks #46 among its holdings.

70 funds tracked by Wall St. Rank hold EPRX as of Q3 2026.

  • Bellevue Group held 2,595,139 shares of Eupraxia Pharmaceuticals worth $23.6M as of Q3 2026.
  • Eupraxia Pharmaceuticals was a new Bellevue Group position in Q3 2026.
  • Eupraxia Pharmaceuticals made up 0.49% of Bellevue Group's portfolio in Q3 2026, its #46 holding.
  • 70 funds tracked by Wall St. Rank held Eupraxia Pharmaceuticals as of Q3 2026.

Based on Bellevue Group's 13F filing for Q3 2026, filed 16 Nov 2026.